NanoVibronix (NAOV) and Its Peers Financial Survey

Share on StockTwits

NanoVibronix (NASDAQ: NAOV) is one of 28 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare NanoVibronix to similar companies based on the strength of its valuation, dividends, institutional ownership, earnings, risk, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and price targets for NanoVibronix and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NanoVibronix 0 0 1 0 3.00
NanoVibronix Competitors 202 884 1521 75 2.55

As a group, “Surgical appliances & supplies” companies have a potential upside of 19.42%. Given NanoVibronix’s competitors higher probable upside, analysts plainly believe NanoVibronix has less favorable growth aspects than its competitors.

Profitability

This table compares NanoVibronix and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NanoVibronix -1,380.78% -180.81% -127.54%
NanoVibronix Competitors -163.27% -192.13% -24.96%

Earnings & Valuation

This table compares NanoVibronix and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
NanoVibronix $240,000.00 -$4.96 million -2.86
NanoVibronix Competitors $1.35 billion $134.43 million 17.38

NanoVibronix’s competitors have higher revenue and earnings than NanoVibronix. NanoVibronix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

14.2% of NanoVibronix shares are owned by institutional investors. Comparatively, 58.3% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 18.7% of NanoVibronix shares are owned by company insiders. Comparatively, 9.5% of shares of all “Surgical appliances & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility and Risk

NanoVibronix has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500. Comparatively, NanoVibronix’s competitors have a beta of 1.14, suggesting that their average share price is 14% more volatile than the S&P 500.

Summary

NanoVibronix competitors beat NanoVibronix on 9 of the 13 factors compared.

About NanoVibronix

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products in the United States, Israel, Europe, India, and internationally through distributor agreements. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.

Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

G-III Apparel Group, Ltd.  Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank
G-III Apparel Group, Ltd. Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank
Xact Kapitalforvaltning AB Has $362,000 Position in Dana Inc
Xact Kapitalforvaltning AB Has $362,000 Position in Dana Inc
Insight Enterprises, Inc.  Position Boosted by Xact Kapitalforvaltning AB
Insight Enterprises, Inc. Position Boosted by Xact Kapitalforvaltning AB
Xact Kapitalforvaltning AB Purchases 1,400 Shares of Spectrum Brands Holdings Inc
Xact Kapitalforvaltning AB Purchases 1,400 Shares of Spectrum Brands Holdings Inc
Los Angeles Capital Management & Equity Research Inc. Purchases 19,350 Shares of JPMorgan Chase & Co.
Los Angeles Capital Management & Equity Research Inc. Purchases 19,350 Shares of JPMorgan Chase & Co.
Microsoft Co.  Position Cut by Wagner Bowman Management Corp
Microsoft Co. Position Cut by Wagner Bowman Management Corp


Leave a Reply

© 2006-2019 Ticker Report